Recent developments in drug treatment strategies for infertility in patients with polycystic ovary syndrome
Stefano Palomba,
No information about this author
Mario Molinaro,
No information about this author
Alice Ingargiola
No information about this author
et al.
Expert Opinion on Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
25(16), P. 2191 - 2202
Published: Oct. 20, 2024
Introduction
Infertility
related
to
polycystic
ovary
syndrome
(PCOS)
represents
a
significant
challenge
for
women
of
reproductive
age.
Over
the
last
few
years,
evidence-based
medicine
has
driven
new
approaches
treating
infertility
in
patients
with
PCOS,
changing
rapidly
and
deeply
clinical
practice.
Language: Английский
The Race for Diagnosis of Polycystic Ovary Syndrome
The Journal of Clinical Endocrinology & Metabolism,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 26, 2024
Journal
Article
Corrected
proof
The
Race
for
Diagnosis
of
Polycystic
Ovary
Syndrome
Get
access
Geralyn
Lambert-Messerlian
Department
Pathology
and
Laboratory
Medicine,
Women
Infants
Hospital
the
Alpert
Medical
School
at
Brown
University,
Providence,
RI
02903,
USADepartment
Obstetrics
Gynecology,
USA
Correspondence:
Lambert-Messerlian,
PhD,
70
Elm
Street,
2nd
floor,
USA.
Email:
[email protected].
https://orcid.org/0000-0002-9440-3411
Search
other
works
by
this
author
on:
Oxford
Academic
Google
Scholar
Clinical
Endocrinology
&
Metabolism,
dgae495,
https://doi.org/10.1210/clinem/dgae495
Published:
26
July
2024
history
Received:
09
Editorial
decision:
12
typeset:
Language: Английский
Gut microbiota biodiversity indices as markers of hyperandrogenemia in women of reproductive age
Acta Biomedica Scientifica (East Siberian Biomedical Journal),
Journal Year:
2024,
Volume and Issue:
9(4), P. 12 - 18
Published: Sept. 25, 2024
Introduction.
Pr
eviously
,
it
was
shown
that
the
“classic”
phenotypes
of
polycystic
ovarian
syndrome
(PCOS)
are
associated
with
significant
decrease
in
gut
microbiota
alpha
diversity
as
compared
healthy
women.
The
aim
study.
T
o
establish
cut-off
points
for
indices,
hyperandrogenism.
Material
and
methods.
he
manuscript
pr
esents
a
sub-study
Eastern
Siberia
PCOS
Epidemiology
Phenotype
Study,
conducted
(Russia)
from
2016
to
2019.
All
participants
(175
women
reproductive
age:
26
(according
Rotterdam
criteria
(2003))
hyperandrogenemia
(increased
levels
total
testosterone
(TT)
and/or
free
androgenindex(FAI),
and/ordehydroepiandrosterone
sulphate
(DHEAS)),
149
–
without
hyperandrogenemia)
were
recruited
during
annual
employment
medical
assessment.
Methods
included
questionnaire
survey,
anthropometry
modified
Ferriman
Gallwey
score,
gynecological
examination,
pelvic
ultrasound,
blood
serum
tests
TT,
DHEAS,
sex
hormone-binding
globulin,
FAI,
prolactin,
thyroid-stimulating
hormone,
17-hydroxyprogesterone.
Five
indices
(amplicon
sequencing
variant,
Shannon
index,
Simpson
Chao
abundance-based
coverage
Index)
estimated
using
amplicon
metasequencing.
Statistical
analysis
ROC-analysis
development
hyperandrogenism
age
PCOS.
Results
.
According
t
results
ROC-analysis,
greatest
sensitivity
moderate
specificity,
high
area
under
curve
established
classifying
or
5.84
0.97,
respectively.
Conclusions.
developed
assessing
most
can
be
useful
monitoring
different
therapeutic
interventions
(prebiotics,
probiotics,
etc.)
hyperandrogenic
Language: Английский
Metabolic syndrome associated with hyperandrogenism in the reproductive age. Hormonal profile in different ethnicities women
Acta Biomedica Scientifica (East Siberian Biomedical Journal),
Journal Year:
2024,
Volume and Issue:
9(5), P. 150 - 158
Published: Nov. 22, 2024
Background
.
Metabolic
syndrome
(MS)
with
hyperandrogenism
comorbidity
in
women
is
considered
a
common
concept;
however,
the
contribution
of
neuroendocrine
regulation
system
indicators
to
this
reproductive
age
remains
unclear.The
aim.
To
analyze
activity
different
ethnic
groups
metabolic
associated
hyperandrogenism.
Materials
and
methods
The
MS
Russian
(n
=
209)
Buryat
84)
group
polycystic
ovary
(PCOS)
23)
10)
were
formed.
Results
In
PCOS
study
noted
higher
levels
anti-Müllerian
hormone
(AMH)
(p
0.030),
testosterone
(Ts)
0.026),
free
androgen
index
(FAI)
<
0.0001),
dehydroepiandrosterone
sulfate
(DHEA-S)
reduced
sex
hormone-binding
globulin
(SHBG)
0.0001)
relation
control;
MS,
we
discovered
increased
values
AMH
0.001),
Ts
FAI
DHEA-S
decreased
SHBG
0.001).
recorded
0.045),
0.002),
0.033),
0.016)
17-OH-progesterone
0.027)
comparison
level
0.006)
0.028).
Conclusion
Women
showed
more
intense
changes
relative
control
regardless
ethnicity.
women,
combined
(MS
PCOS)
was
accompanied
by
greater
number
hormonal
compared
monosyndrome
than
women.
data
obtained
indicate
need
assess
content
these
metabolites
PCOS,
taking
into
account
Language: Английский